Scoring Systems for Estimating the Risk of Anticoagulant‐Associated Bleeding

  title={Scoring Systems for Estimating the Risk of Anticoagulant‐Associated Bleeding},
  author={Anna L Parks and M. Fang},
  journal={Seminars in Thrombosis and Hemostasis},
  • Anna L Parks, M. Fang
  • Published 2017
  • Medicine
  • Seminars in Thrombosis and Hemostasis
  • Abstract Anticoagulant medications are frequently used to prevent and treat thromboembolic disease. However, the benefits of anticoagulants must be balanced with a careful assessment of the risk of bleeding complications that can ensue from their use. Several bleeding risk scores are available, including the Outpatient Bleeding Risk Index, HAS‐BLED, ATRIA, and HEMORR2 HAGES risk assessment tools, and can be used to help estimate patients’ risk for bleeding on anticoagulants. These tools vary by… CONTINUE READING
    9 Citations

    Paper Mentions

    Interventional Clinical Trial
    Cipherome's Lighthouse is a clinical decision support tool that incorporates a patient's pharmacogenetic information to determine therapeutic strategy, including determining… Expand
    ConditionsBleeding, Ischemic Stroke, Myocardial Infarction, (+2 more)
    InterventionDiagnostic Test
    Observational Clinical Trial
    The study goal is to investigate the impact of genetic variants, demographics, and environmental factors in subjects (status post myocardial infarction and percutaneous coronary… Expand
    ConditionsIschemic Stroke, Recurrent Myocardial Infarction, Stent Thrombosis
    Clinical Scoring Systems in Thrombosis and Hemostasis.
    • A. Cuker
    • Medicine
    • Seminars in thrombosis and hemostasis
    • 2017
    • 6
    • PDF
    Pulmonary embolism: Care standards in 2018.
    • 9
    Primary thromboprophylaxis for inpatients with advanced cancer
    • Highly Influenced
    • PDF